Veterinary/Animal Vaccines Market Analysis By Product (Attenuated Live, Inactivated, Subunit, DNA and Recombinant), By Animal Type (Companion Animal, Cattle, Poultry, Equine), And Segment Forecasts, 2014 - 2025

  • ID: 4452075
  • Report
  • 100 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Bayer AG
  • Biogenesis Bago S.A.
  • Boehringer Ingelheim
  • Heska Corporation
  • Merck & Co. Inc.
  • Virbac Inc.
  • MORE
The global veterinary vaccines market is expected to reach USD 12.6 billion by 2025. Rise in the outbreak of livestock diseases, expanding livestock population and increasing zoonotic diseases are driving the market growth. Increasing awareness regarding commercially available vaccines is pushing the adoption globally. However, higher costs associated with storage is challenging the growth and restricting the entry of new players.

This market has emerged to be one of the profitable investment options seeking attention and investments from both government and non-government players. Rise in the number of pet owners and their shifting focus towards healthy animal practices are some other factors propelling the growth of the market. Government intervention in distribution channel on the other hand, is affecting the profitability of the veterinary vaccine manufacturers. The bulk purchase and supply of livestock vaccines by countries such as India and Alaska that have large livestock population are reducing the profit margins of the vaccine manufacturers’ through bulk pricing.

Further Key Findings From the Report Suggest:
  • Attenuated vaccines emerged as the largest segment as a result of the benefits such as improved effectivity and enhanced long-term prevention
  • Cattle vaccines accounted for the largest share in the animal type segment owing to the rise in the demand for safe animal products
  • Companion animal vaccines segment is the fastest growing segment owing to the increase in number of pet owners worldwide
  • North America dominated the market with the largest share in 2016. Constantly rising awareness regarding animal health and increasing commercialization of animal products are facilitating dominance of the region during the forecast period.
  • Asia Pacific is projected to witness swift growth during the forecast period owing to the speedy adoption of veterinary vaccines for quality food products and better animal health
  • Key players including Zoetis, Virbac Inc. Indian Immunological Limited, Heska Corp., Boehringer Inghlem, Bayer Pharma Ag, Merck Animal Health and Biogenesis Bago dominated the global veterinary vaccines market.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • Biogenesis Bago S.A.
  • Boehringer Ingelheim
  • Heska Corporation
  • Merck & Co. Inc.
  • Virbac Inc.
  • MORE
Chapter 1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
1.3 Approaches for market estimation
1.3.1 Approach 1: Demand Analysis & Bottom up Approach
1.3.2 Approach 2: Top down market estimation
1.3.3 Approach 3: Commodity flow and bottom up market estimation
1.3.4 Approach 4: KoL perspective based market sizing

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Veterinary Vaccines Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Penetration & growth prospect mapping
3.5 Veterinary Vaccines Market - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s
3.7 Value Chain Analysis

Chapter 4 Veterinary Vaccines Market: Product Estimates & Trend Analysis
4.1 Veterinary vaccines market: Product type movement analysis
4.2 Attenuated Live Vaccines
4.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
4.3 Inactivated Vaccines
4.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
4.4 Subunit vaccines
4.4.1 Market estimates and forecast, 2014 - 2025 (USD Million)
4.5 DNA vaccines
4.5.1 Market estimates and forecast, 2014 - 2025 (USD Million)
4.5.2 Recombinant vaccines
4.5.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)

Chapter 5 Veterinary Vaccines Market: By Animal Type Estimates & Trend Analysis
5.1 Veterinary Vaccines Market: Animal type movement analysis
5.2 Companion animal vaccines, by disease type
5.2.1.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.2 Canine
5.2.2.1 Market estimates and forecast, 2014 - 2025(USD Million)
5.2.3 Canine Distemper
5.2.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.4 Kennel cough (Parainfluenza)
5.2.4.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.5 Parvovirus
5.2.5.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.6 Canine Herpes
5.2.6.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.7 Lyme Disease
5.2.7.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.8 Feline
5.2.8.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.9 Feline calcivirus
5.2.9.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.10 Feline Infectious Peritonitis (FIP)
5.2.10.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.11 Feline Immunodeficiency Virus (FIV)
5.2.11.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.3 Cattle vaccines, by disease type
5.3.1 Bovine Respiratory Syncytial Virus (BRSV)
5.3.1.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.3.2 Enzootic Bronchopneu
5.3.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.3.3 Infectious Bovine Rhinotracheitis (IBR)
5.3.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.3.4 Bovine Viral Diarrhea (BVD)
5.3.4.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.4 Poultry vaccines, by disease type
5.4.1 Infectious Bronchitis in Poultry
5.4.1.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.4.2 Avian Influenza
5.4.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.4.3 Newcastle disease
5.4.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.4.4 Marek’s disease
5.4.4.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.5 Pig vaccines, by disease
5.5.1 Porcine reproductive and respiratory syndrome
5.5.1.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.5.2 Swine influenza
5.5.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.5.3 Swine pneumonia
5.5.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.6 Equine vaccines, by disease
5.6.1 Encephalomyelitis
5.6.1.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.6.2 Rhino pneumonitis
5.6.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.6.3 Horse flu (Influenza)
5.6.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)

Chapter 6 Veterinary Vaccines Market: Regional Estimates & Trend Analysis, by Product and Animal Type
6.1 Veterinary vaccines market: Regional movement analysis
6.2 North America
6.2.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.2.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
6.2.3 U.S.
6.2.3.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.2.3.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
6.2.4 Canada
6.2.4.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.2.4.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
6.3 Europe
6.3.1. Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.3.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
6.3.3 U.K.
6.3.3.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.3.3.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
6.3.4 Germany
6.3.4.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.3.4.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.4.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)

6.4.2 India
6.4.2.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.4.2.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
6.4.3 China
6.4.3.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.4.3.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
6.5 Latin America
6.5.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.5.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.5.2.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
6.5.3 Mexico
6.5.3.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.5.3.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
6.6 Middle East and Africa (MEA)
6.6.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.6.1 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
6.6.2.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)

Chapter 7 Competitive Landscape
7.1 Company Profiles
7.1.1 Merck & Co., Inc.
7.1.1.1 Company overview
7.1.1.2 Financial Performance
7.1.1.3 Product benchmarking
7.1.1.4 Strategic initiatives
7.1.2 Zoetis
7.1.2.1 Company Overview
7.1.2.2 Financial Performance
7.1.2.3 Product Benchmarking
7.1.2.4 Strategic Overview
7.1.3 Boehringer Ingelheim
7.1.3.1 Company Overview
7.1.3.2 Financial Performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic Initiatives
7.1.4 Bayer AG
7.1.4.1 Company Overview
7.1.4.2 Financial Performance
7.1.4.3 Product Benchmarking
7.1.4.4 Strategic Initiatives
7.1.5 Virbac Inc.
7.1.5.1 Company Overview
7.1.5.2 Financial Performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic Initiatives
7.1.6 Biogenesis Bago S.A.
7.1.6.1 Company Overview
7.1.6.2 Financial Performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic Initiatives
7.1.7 Indian Immunological Limited
7.1.7.1 Company Overview
7.1.7.2 Financial Performance
7.1.7.3 Product Benchmarking
7.1.7.4 Strategic Initiatives
7.1.8 Heska Corporation
7.1.8.1 Company Overview
7.1.8.2 Financial Performance
7.1.8.3 Product Benchmarking
7.1.8.4 Strategic Initiatives

List of Tables

Table 1 North America veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 2 North America veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
Table 3 U.S. veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 4 U.S. veterinary vaccines market, by animal type, 2014 - 2025 (USD million)
Table 5 Canada veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 6 Canada veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
Table 7 Europe veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 8 Europe veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
Table 9 U.K. veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 10 U.K. veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
Table 11 Germany veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 12 Germany veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
Table 13 Asia Pacific veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 14 Asia Pacific veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
Table 15 Japan veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 16 Japan veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
Table 17 China veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 18 China veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
Table 19 Latin America veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 20 Latin America veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
Table 21 Brazil veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 22 Brazil veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
Table 23 Mexico veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 24 Mexico veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
Table 25 MEA veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 26 MEA veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
Table 27 South Africa veterinary vaccines market, by product, 2014 - 2025 (USD Million)
Table 28 South Africa veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary (USD Million)
FIG. 8 Value Chain Analysis : Veterinary Vaccines Market
FIG. 9 Market trends & outlook
FIG. 10 Market segmentation & scope
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping
FIG. 14 Penetration & growth prospect mapping
FIG. 15 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 16 Porter’s Five Forces Analysis
FIG. 17 Veterinary vaccines market product outlook key takeaways
FIG. 18 Veterinary vaccines market: Product movement analysis
FIG. 19 Attenuated live vaccines market, 2014 - 2025 (USD Million)
FIG. 20 Inactivated vaccines market, 2014 - 2025 (USD Million)
FIG. 21 Subunit vaccines market, 2014- 2025 (USD Million)
FIG. 22 DNA vaccines market, 2014 - 2025 (USD Million)
FIG. 23 Recombinant vaccines market, 2014 - 2025 (USD Million)
FIG. 24 Veterinary vaccines market animal type outlook key takeaways
FIG. 25 Veterinary vaccines market: Animal type movement analysis
FIG. 26 Companion animal vaccines market, 2014 - 2025 (USD Million)
FIG. 27 Canine disease market, 2014 - 2025 (USD Million)
FIG. 28 Canine distemper market, 2014 - 2025 (USD Million)
FIG. 29 Kennel cough market, 2014 - 2025 (USD Million)
FIG. 30 Parvovirus market, 2014 - 2025 (USD Million)
FIG. 31 Canine herpes market, 2014 - 2025 (USD Million)
FIG. 32 Lyme disease market, 2014 - 2025 (USD Million)
FIG. 33 Feline vaccines market, 2014 - 2025 (USD Million)
FIG. 34 Feline calcivirus market, 2014 - 2025 (USD Million)
FIG. 35 Feline Infectious Peritonitis market, 2014 - 2025 (USD Million)
FIG. 36 Feline Immunodeficiency Virus market, 2014 - 2025 (USD Million)
FIG. 37 BRSV market, 2014 - 2025 (USD Million)
FIG. 38 Enzootic Bronchopneu market, 2014 - 2025 (USD Million)
FIG. 39 IBR market, 2014 - 2025 (USD Million)
FIG. 40 BVD market, 2014 - 2025 (USD Million)
FIG. 41 IBP market, 2014 - 2025 (USD Million)
FIG. 42 Avian influenza market, 2014 - 2025 (USD Million)
FIG. 43 Newcastle Disease market, 2014 - 2025 (USD Million)
FIG. 44 Marek’s disease market, 2014 - 2025 (USD Million)
FIG. 45 PRRS market, 2014 - 2025 (USD Million)
FIG. 46 Swine influenza market, 2014 - 2025 (USD Million)
FIG. 47 Swine pneumonia market, 2014 - 2025 (USD Million)
FIG. 48 Encephalomyelitis market, 2014 - 2025 (USD Million)
FIG. 49 Rhino pneumonitis market, 2014 - 2025 (USD Million)
FIG. 50 Horse flu market, 2014 - 2025 (USD Million)
FIG. 51 Regional market place: Key takeaways
FIG. 52 Veterinary vaccines: regional movement analysis
FIG. 53 North America market, 2014 - 2025 (USD Million)
FIG. 54 U.S. market, 2014 - 2025 (USD Million)
FIG. 55 Canada market, 2014 - 2025 (USD Million)
FIG. 56 Europe market, 2014 - 2025 (USD Million)
FIG. 57 U.K. market, 2014 - 2025 (USD Million)
FIG. 58 Germany market, 2014 - 2025 (USD Million)
FIG. 59 Asia-Pacific market, 2014 - 2025 (USD Million)
FIG. 60 India market, 2014 - 2025 (USD Million)
FIG. 61 China market, 2014 - 2025 (USD Million)
FIG. 62 Latin America market, 2014 - 2025 (USD Million)
FIG. 63 Brazil market, 2014 - 2025 (USD Million)
FIG. 64 Mexico market, 2014 - 2025 (USD Million)
FIG. 65 MEA market, 2014 - 2025 (USD Million)
FIG. 66 South Africa market, 2014 - 2025 (USD Million)
FIG. 67 Strategy framework
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Merck & Co. Inc.
  • Zoetis
  • Boehringer Ingelheim
  • Bayer AG
  • Virbac Inc.
  • Biogenesis Bago S.A.
  • Indian Immunological Limited
  • Heska Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll